β3-Adrenergic relaxation of bovine iris sphincter

被引:17
作者
Geyer, O [1 ]
Bar-Ilan, A
Nachman, R
Lazar, M
Oron, Y
机构
[1] Sourasky Med Ctr, Dept Ophthalmol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel
关键词
bovine iris sphincter; relaxation; beta(3)-Adrenergic receptor; bupranolol; BRL; 37344;
D O I
10.1016/S0014-5793(98)00631-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bovine iris sphincter in vitro responded to beta-adrenergic stimulation with pronounced relaxation (EC50 Of isoproterenol=0.3 nM), which was potentiated by the cAMP phosphodiesterase inhibitor, isobutylmethylxanthine, and mimicked by the adenylyl cyclase activator, forskolin, The beta(1)/beta(2) antagonist, propranolol, exhibited low potency with calculated K-i of 200 nM. The beta(3)-selective antagonist, bupranolol, exhibited a biphasic inhibition profile, with calculated K(i)s of approximately 20-50 and 200-300 nM. The beta(3)-selective agonist, BRL 37344, elicited 70% of maximal relaxation (EC50=30 nM), When relaxation was induced by BRL 37344, bupranolol exhibited much higher potency (calculated K-i = 1 nM). Our data suggest that the beta-adrenergic relaxation response in bovine iris sphincter is mediated by a mixed population of beta-adrenergic receptors, with a predominant contribution of atypical, most likely beta(3) subtype, receptors. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:356 / 358
页数:3
相关论文
共 17 条
[1]   MEDIATION OF MOST ATYPICAL EFFECTS BY SPECIES HOMOLOGS OF THE BETA(3)-ADRENOCEPTOR [J].
BLIN, N ;
NAHMIAS, C ;
DRUMARE, MF ;
STROSBERG, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) :911-919
[2]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121
[3]   COEXISTENCE OF BETA-1-ADRENOCEPTORS, BETA-2-ADRENOCEPTORS, AND BETA-3-ADRENOCEPTORS IN DOG FAT-CELLS AND THEIR DIFFERENTIAL ACTIVATION BY CATECHOLAMINES [J].
GALITZKY, J ;
REVERTE, M ;
PORTILLO, M ;
CARPENE, C ;
LAFONTAN, M ;
BERLAN, M .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (03) :E403-E412
[4]  
GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895
[5]   BETA-ADRENOCEPTOR AGONIST MEDIATED RELAXATION OF RAT ISOLATED RESISTANCE ARTERIES - A ROLE FOR THE ENDOTHELIUM AND NITRIC-OXIDE [J].
GRAVES, J ;
POSTON, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (03) :631-637
[6]   TISSUE DISTRIBUTION OF BETA-3-ADRENERGIC RECEPTOR MESSENGER-RNA IN MAN [J].
KRIEF, S ;
LONNQVIST, F ;
RAIMBAULT, S ;
BAUDE, B ;
VANSPRONSEN, A ;
ARNER, P ;
STROSBERG, AD ;
RICQUIER, D ;
EMORINE, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :344-349
[7]   COEXISTENCE OF 3 BETA-ADRENOCEPTOR SUBTYPES IN WHITE FAT-CELLS OF VARIOUS MAMMALIAN-SPECIES [J].
LANGIN, D ;
PORTILLO, MP ;
SAULNIERBLACHE, J ;
LAFONTAN, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 199 (03) :291-301
[8]   MOLECULAR-CLONING OF A HUMAN BETA-3-ADRENERGIC RECEPTOR CDNA [J].
LELIAS, JM ;
KAGHAD, M ;
RODRIGUEZ, M ;
CHALON, P ;
BONNIN, J ;
DUPRE, I ;
DELPECH, B ;
BENSAID, M ;
LEFUR, G ;
FERRARA, P ;
CAPUT, D .
FEBS LETTERS, 1993, 324 (02) :127-130
[9]   Functional identification of rat atypical beta-adrenoceptors by the first beta(3)-selective antagonists, aryloxypropanolaminotetralins [J].
Manara, L ;
Badone, D ;
Baroni, M ;
Boccardi, G ;
Cecchi, R ;
Croci, T ;
Giudice, A ;
Guzzi, U ;
Landi, M ;
LeFur, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (03) :435-442
[10]   Nitric oxide-mediated beta(2)-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats [J].
MartinezCuesta, MA ;
Moreno, L ;
Pique, JM ;
Bosch, J ;
Rodrigo, J ;
Esplugues, JV .
GASTROENTEROLOGY, 1996, 111 (03) :727-735